NEWS

ICDRA’s 2027 hosting call, a trust mark for well-being products, INTERPOL’s health-security pact, African trial capacity and a breast-cancer manual.

A zero-approval week at the FDA, and two decisions that matter more: Anktiva’s label extended on reused evidence, plus a new rare disease framework.

Five WHO signals for buyers: NTD supply chains to 2030, 24-hour outbreak detection, the UN pandemic declaration, a live misoprostol review and a TB toolkit.